Kailera
Clinical trials sponsored by Kailera, explained in plain language.
-
New weekly shot could help shed pounds without diabetes
Disease control Recruiting nowThis study tests a new weekly injection called KAI-9531 to help people with obesity or overweight lose weight. It is for adults who do not have diabetes but have weight-related health problems like high blood pressure or sleep apnea. The study compares the drug to a placebo over …
Phase: PHASE3 • Sponsor: Kailera • Aim: Disease control
Last updated Jun 08, 2026 13:18 UTC
-
Weekly shot could help people with obesity and diabetes shed pounds and lower blood sugar
Disease control Recruiting nowThis study tests a new weekly injection called KAI-9531 in 1700 adults with obesity or overweight and type 2 diabetes. The goal is to see if it helps people lose more weight and improve blood sugar control compared to a placebo. Participants must have a BMI of 27 or higher and be…
Phase: PHASE3 • Sponsor: Kailera • Aim: Disease control
Last updated Jun 08, 2026 13:04 UTC
-
New daily pill aims to help shed pounds in obesity trial
Disease control Recruiting nowThis study tests an experimental daily pill, KAI-7535, to see if it helps people with obesity or overweight lose more weight than a placebo. The trial includes 320 adults who also have at least one weight-related health problem like high blood pressure or sleep apnea. Participant…
Phase: PHASE2 • Sponsor: Kailera • Aim: Disease control
Last updated May 29, 2026 14:15 UTC
-
New obesity drug KAI-9531 aims to outperform semaglutide in major trial
Disease control Recruiting nowThis study tests a new weekly injection, KAI-9531, to see if it helps people with obesity lose more weight than the existing drug semaglutide or a placebo. About 1,200 adults with a BMI of 35 or higher who have tried to lose weight before will take part. The main goal is to measu…
Phase: PHASE3 • Sponsor: Kailera • Aim: Disease control
Last updated May 26, 2026 12:10 UTC